European stocks closed mostly higher on Wednesday, thanks largely to some strong corporate earnings updates, and expectations of an interest rate reduction ...

In an earnings call on July 29th, in which the company reported a 13% increase in half-year profits, he said about Britain ...

Ever since President Donald Trump started promising to slap tariffs on pharmaceutical imports, drugmakers have unveiled a ...

Donald Trump has sacked America’s top statistician after official data showed a sharp slowdown in the US jobs market. The US ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The research service ...

Demant A/S posted the largest decline among large stocks during the session, declining 8.8%, followed by GN Store Nord A/S shares, which dropped 7.8%. Shares of Novo Nordisk A/S fell 6.3%.

The UK’s largest listed companies are turning their heads towards the glimmer of the Nasdaq after growing impatient at the lacklustre performance of the London Stock Exchange. Chief among them is ...

Hansa Biopharma AB, which recently restructured and named a new CEO, has announced three leadership appointments.

Stock markets were mixed on Tuesday as investors started turning their attention from trade deals to a slew of company ...

Stock markets were mixed on Tuesday as investors started turning their attention from trade deals to a slew of company ...

AstraZeneca to spend $50 billion in US production build out to avert tariff threat Texas, Virginia, Indiana and Massachusetts are all part of the drugmaker’s plans.

Ahead of the 10-year anniversary of Tagrisso’s FDA approval this fall, AstraZeneca has debuted the first DTC commercial for the lung cancer med.